Summary
Increasing evidence has focusesed on the endocannabinoid system as a relevant player in the induction of aberrant synaptic plasticity and related addictive phenotype following chronic excessive alcohol drinking. In addition, the endocannabinoid system is implicated in the pathogenesis of alcoholic liver disease. Interestingly, whereas the involvement of CB 1 receptors in alcohol rewarding properties is established, the central and peripheral action of CB 2 signalling is still to be elucidated. This review aims at giving the input to deepen knowledge on the role of the endocannabinoid system, highlighting the advancing evidence that suggests that CB 1 and CB 2 receptors may play opposite roles in the regulation of both the reinforcing properties of alcohol in the brain and the mechanisms responsible for cell injury and inflammation in the hepatic tissue. The manipulation of the endocannabinoid system could represent a bi-faceted strategy to counteract alcohol-related dysfunction in central transmission and liver structural and functional disarrangement.
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| RE SULTS

| ECS-mediated alcohol reinforcing effects
Alcohol produces its effects through actions on multiple brain circuits and involves neuroadaptive changes not only in adulthood but especially in critical periods of development. 22, [25] [26] [27] [28] [29] [30] [31] The past 2 decades of clinical research and data derived from preclinical models of alcohol addiction point to the glutamatergic and the GABAergic systems as the main target of alcohol activity in the mesocorticolimbic system, [32] [33] [34] [35] [36] [37] [38] and this results in a downregulation of NPY expression and the occurrence of withdrawal symptoms following ACD suspension. 21, 22 Moreover, the study showed that CB 1 receptor blockade by the antagonist/inverse agonist AM281 is able to increase NPY expression, decrease ACD seeking-behaviour and boost homeostatic functional recovery. 21, 22 This is in accordance with AEA and 2-AG effect on CB 1 receptors on glutamate terminals, and the resulting decrease in glutamate release and downregulation in NPY mRNA levels. 72, 73 Overall CB 1 receptor signalling in the mesocorticolimbic system is a fundamental prerequisite for the expression of motivation to seek rewarding stimuli ( Figure 1A ).
| CB 2 receptors: a novel target for addiction
When cannabinoid receptors type 2 (CB 2 receptor) were first cloned, they were tagged as peripheral receptors. 74 However, recent studies suggest that CB 2 receptors are expressed in the nervous systemcertainly in activated microglia and in some neuron subsets. 75 Indeed, CB 2 receptors have been recently involved in synaptic plasticity, 76, 77 and latest studies investigated the role of CB 2 receptors in models of alcohol, nicotine and cocaine addiction [78] [79] [80] suggesting a role, not well defined yet, for CB 2 receptors in the modulation of drug reward-related behaviours. Given that dysfunction in DA signalling is a major abnormality in psychiatric and neurological disorders, 90 these studies provide a basis for further analysis of the role of CB 2 receptors in the aetiology of central disorders associated with DA dysregulation and for the development of drugs that selectively target eCB receptors ( Figure 1A ).
| ECS-mediated effects in alcoholic liver disease
The ECS and its receptors have emerged as major regulators of several pathophysiological mechanisms responsible for cell injury and inflammatory response that are associated with chronic liver disease progression. [91] [92] [93] Indeed, under physiological conditions, both hepatocytes and non-parenchymal cells (ie Kupffer) are able to produce eCB, but the basal expression of CB 1 receptors and CB 2 receptors in the adult healthy liver is low or even absent. 94, 95 Notably, eCB synthesis and the hepatic expression of both cannabinoid receptors are upregulated during chronic liver damage. 91 Studies applying genetic or pharmacological inactivation of cannabinoid receptors showed that CB 1 receptors and CB 2 receptors exert opposite effects on fibrogenesis: CB 1 receptors have profibrogenic effects, 94 while CB 2 receptors can inhibit or reverse hepatic fibrogenesis and exert anti-inflammatory effects, 96 thus protecting from liver damage progression ( Figure 1B Overall these data pinpoint on the CB 1 receptor signalling pathway as a novel paradigm to explain the molecular mechanisms underlying alcohol-induced liver damage. Moreover, hepatic CB 2 receptors emerge as protective targets not only for their antifibrogenic properties but also for promoting hepatocyte survival and regeneration.
The rising availability and use of legal cannabis by individuals who also consume alcohol, make the assessment of cannabis impact on alcohol-related pathologies mandatory. Daily cannabis smoking has been pointed as an additive factor in the evolution of ALD. 5 However, the synergistic effects of cannabis and alcohol on liver disease progression remains unclear and further research in this field is highly needed.
| D ISCUSS I ON
The rapidly advancing evidence on the neurobiology of the ECS suggests that CB 1 properties of alcohol and to recover liver architecture and functional disarrangement. Further elucidation on the eCB-alcohol crosstalk, will help finding specific agents able to respond to complex therapeutic demand.
| ME THODS
The literature search targeted evidence-based guidelines, evidencebased summaries, systematic reviews and recent experimental research on alcohol and endocannabinoid central, peripheral and behavioural effects.
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